Ind-Swift Laboratories
INDSWFTLAB · Pharma > Pharmaceuticals & Drugs · Chairman: N R Munjal · MD: N R Munjal · Listing date: July 17, 1997 · Employees: 1531 · Chandigarh · http://www.indswiftlabs.com

Stock Price vs Company Growth
1d
1.9%
1w
0.2%
1m
9.0%
3m
34.9%
6m
4.1%
1y
27.0%
5y
30.3%
10y
13.2%
all
4.8%

Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price

₹ 115 1.9%
110
180
Company Overview

Sales
1,004 Cr
Growth: 9.6%
Profit after Tax
-95.8 Cr
Growth: 20.5%
Small Cap
679 Cr
P/E: 2.3x
Industry P/E: 41.6x
Fundamentals

Sales (Cr) ₹ 1,004
Growth 9.6%
EBITDA 7.0%
P/S 0.7x
Dividend 0.0%
P/E 2.3x
Book Value ₹ 158
PEG Ratio 0.2x
ROE -12.9%
P/B 0.7x
Shareholding Pattern

Institutions
Edelweiss India Special Situations Fund Ii
10.43 %
Ec Special Situations Fund
6.82 %
Ashokkumar Chandak
2.79 %
Eisaf Ii Onshore Fund
2.24 %
Sri Ganesh Biotech Private Limited
1.26 %
Promoters
Essix Biosciences Limited
21.71 %
Ind Swift Ltd
16.08 %
N.R. Munjal
1.56 %
Rishav Mehta
0.77 %
Himanshu Jain
0.69 %
Others
Increase    Decrease    No change
Company Profile Detailed

Ind-Swift Laboratories is a part of the Ind-swift Group and is based at Chandigarh, India. It has been promoted by Ind-Swift Limited in a joint venture with the Punjab State Industrial Development Corporation Limited (PSIDC). The group has established a strong reputation as innovators in the Indian pharmaceutical industry. Ind-Swift Laboratories Ltd. went public in 1997 and concentrated on the manufacturing of Active Pharmaceutical Ingredients (API).
Investors (112)
Followers (1)